- Home
- FTHM vs ECOR Comparison
FTHM vs ECOR Comparison
Compare FTHM & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FTHM | ECOR |
|---|---|---|
| Founded | 2010 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.9M | 39.6M |
| IPO Year | 2020 | 2018 |
Fundamental Metrics
Financial Performance| Metric | FTHM | ECOR |
|---|---|---|
| Price | $1.29 | $4.90 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $2.50 | ★ $25.50 |
| AVG Volume (30 Days) | ★ 195.5K | 79.4K |
| Earning Date | 11-11-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $421,612,000.00 | $29,835,000.00 |
| Revenue This Year | $25.22 | $24.55 |
| Revenue Next Year | $16.19 | $41.13 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 32.78 | 27.90 |
| 52 Week Low | $0.65 | $4.16 |
| 52 Week High | $3.37 | $19.49 |
Technical Indicators
Market Signals| Indicator | FTHM | ECOR |
|---|---|---|
| Relative Strength Index (RSI) | 46.96 | 47.21 |
| Support Level | $1.18 | $4.77 |
| Resistance Level | $1.33 | $5.14 |
| Average True Range (ATR) | 0.14 | 0.36 |
| MACD | 0.03 | -0.07 |
| Stochastic Oscillator | 51.83 | 23.39 |
Price Performance
Historical ComparisonAbout FTHM Fathom Holdings Inc.
Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service (SaaS) offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent. The company has three reportable segments namely Real Estate Brokerage, Mortgage and Technology. The brands of the company include Fathom Realty, Dagley Insurance, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title. Majority of revenue is from Real Estate segment.
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.